Inhibiteurus selectifs de la cyclo-oxygenase-2 et tube digestif
Tunisie Medicale [La]. 2002; 80 (8): 427-33
em Fr
| IMEMR
| ID: emr-61116
Biblioteca responsável:
EMRO
ABSTRACT
The use of non steroidal anti-inflammatory drugs [NSAIDS] is tempered by the development of side effects primarily in the gastro-intestinal tract. These effects result mainly from inhibition of the enzyme cyclo-oxygenase [COX]-1. Two NSAIDS [celecoxib and rofecoxib] COX-2 specific inhibitors had considerably lower ulcerogenic rates and lower serious gastro intestinal side effects when compared with other NSAIDs used in rhumatoid arthritis and osteoarthritis. However, the exact place of COX-2 specific inhibitors remain to be determined as compared with the association of other NSAIDs and proton pump inhibitors in the elderly. The efficacy of COX-2 specific inhibitors in digestive tumors is still unclear
Buscar no Google
Índice:
IMEMR
Assunto principal:
Úlcera Péptica
/
Anti-Inflamatórios não Esteroides
/
Sistema Digestório
Limite:
Humans
Idioma:
Fr
Revista:
Tunisie Med.
Ano de publicação:
2002